Speech Treatment for Minimally Verbal Children With ASD and CAS
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 5
Maximum Age: 18
Healthy Volunteers: f
View:
• Meets criteria for Autism Spectrum Disorder
• Able to correctly repeat at least 2 syllables
• Meets criteria for Childhood Apraxia of Speech
• Lives in an environment where child is exposed to English at least 50% of the time
Locations
United States
Massachusetts
MGH Institute of Health Professions
RECRUITING
Boston
Contact Information
Primary
Karen V Chenausky, Ph.D.
kvchenausky@mghihp.edu
617-726-2405
Backup
Michael Moody
mjmoody@partners.org
617-643-4658
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2026-11-30
Participants
Target number of participants: 20
Treatments
Experimental: CAS Treatment for MV ASD
Participants will receive CAS treatment, modified for minimally verbal children with autism
Related Therapeutic Areas
Sponsors
Leads: MGH Institute of Health Professions